Magnesium in acute myocardial infarction: Scientific, statistical, and economic rationale for its use

Cardiovascular Drugs and Therapy

Volumn 10, Issue 3, 1996, Pages 297-301

  Antman, Elliott M ^a   Seelig, Mildred S ^b   Fleischmann, Kirsten ^a   Lau, Joseph ^c   Kuntz, Karen ^a   Berkey, Catherine S ^d   McIntosh, Martin W ^e  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b University of North Carolina at Chapel Hill   (United States)

^c TUFTS MEDICAL CENTER   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e HARVARD UNIVERSITY   (United States)

Author keywords

acute myocardial infarction; MAGIC; magnesium

Indexed keywords

MAGNESIUM;

ACUTE HEART INFARCTION; CLINICAL TRIAL; DRUG COST; EDITORIAL; HEALTH ECONOMICS; HUMAN; PRIORITY JOURNAL; STATISTICS;

CLINICAL TRIALS; COST-BENEFIT ANALYSIS; HOSPITALIZATION; HUMANS; MAGNESIUM; META-ANALYSIS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; TREATMENT OUTCOME;

EID: 0029759849     PISSN: 09203206     EISSN: 15737241     Source Type: Journal    
DOI: 10.1007/BF02627951     Document Type: Editorial

References (55)